Literature DB >> 10675356

Differential immune responses to alpha-gal epitopes on xenografts and allografts: implications for accommodation in xenotransplantation.

M Tanemura1, D Yin, A S Chong, U Galili.   

Abstract

Xenograft recipients produce large amounts of high-affinity anti-Gal IgG in response to Galalpha1-3Galbeta1- 4GlcNAc-R (alpha-gal) epitopes on the graft. In contrast, ABO-mismatched allograft recipients undergo "accommodation," a state of very weak immune response to ABO antigens. These differences in anti-carbohydrate immune response were studied in alpha1,3galactosyltransferase knock-out mice. Pig kidney membranes administered to these mice elicited extensive production of anti-Gal IgG, whereas allogeneic kidney membranes expressing alpha-gal epitopes elicited only a weak anti-Gal IgM response. Anti-Gal IgG response to xenograft membranes depended on helper T cell activation and was inhibited by anti-CD40L antibody. These T cells were activated by xenopeptides and not by alpha-gal epitopes. Moreover, allogeneic cell membranes manipulated to express xenoproteins also induced anti-Gal IgG response. Xenoglycoproteins with alpha-gal epitopes are processed by anti-Gal B cells. Xenopeptides presented by these cells activate a large repertoire of helper T cells required for the differentiation of anti-Gal B cells into cells secreting anti-Gal IgG. Alloglycoproteins with alpha- gal epitopes have very few immunogenic peptides and fail to activate helper T cells. Similarly, ineffective helper T-cell activation prevents a strong immune response to blood group antigens in ABO-mismatched allograft recipients, thus enabling the development of accommodation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10675356      PMCID: PMC377438          DOI: 10.1172/JCI7358

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  Renal transplantation across the ABO barrier--a 9-year experience.

Authors:  M Slapak; N Digard; M Ahmed; T Shell; F Thompson
Journal:  Transplant Proc       Date:  1990-08       Impact factor: 1.066

2.  Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells.

Authors:  U Galili; S B Shohet; E Kobrin; C L Stults; B A Macher
Journal:  J Biol Chem       Date:  1988-11-25       Impact factor: 5.157

3.  Early postoperative monitoring of natural anti-A and anti-B isoantibodies in ABO-incompatible living donor renal allografts.

Authors:  R Reding; J P Squifflet; D Latinne; M De Bruyère; Y Pirson; G P Alexandre
Journal:  Transplant Proc       Date:  1987-02       Impact factor: 1.066

4.  Present experiences in a series of 26 ABO-incompatible living donor renal allografts.

Authors:  G P Alexandre; J P Squifflet; M De Bruyère; D Latinne; R Reding; P Gianello; M Carlier; Y Pirson
Journal:  Transplant Proc       Date:  1987-12       Impact factor: 1.066

5.  Structure of crossreactive human histocompatibility antigens HLA-A28 and HLA-A2: possible implications for the generation of HLA polymorphism.

Authors:  J A López de Castro; J L Strominger; D M Strong; H T Orr
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

6.  The molecular basis of evolution.

Authors:  A C Wilson
Journal:  Sci Am       Date:  1985-10       Impact factor: 2.142

7.  Isolation of a cDNA encoding a murine UDPgalactose:beta-D-galactosyl- 1,4-N-acetyl-D-glucosaminide alpha-1,3-galactosyltransferase: expression cloning by gene transfer.

Authors:  R D Larsen; V P Rajan; M M Ruff; J Kukowska-Latallo; R D Cummings; J B Lowe
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

8.  Blood group isoantibody stimulation in man by feeding blood group-active bacteria.

Authors:  G F Springer; R E Horton
Journal:  J Clin Invest       Date:  1969-07       Impact factor: 14.808

9.  Immunochemistry of I/i-active oligo- and polyglycosylceramides from rabbit erythrocyte membranes. Characterization of linear, di-, and triantennary neolactoglycosphingolipids.

Authors:  H Egge; M Kordowicz; J Peter-Katalinić; P Hanfland
Journal:  J Biol Chem       Date:  1985-04-25       Impact factor: 5.157

10.  Human natural anti-alpha-galactosyl IgG. II. The specific recognition of alpha (1----3)-linked galactose residues.

Authors:  U Galili; B A Macher; J Buehler; S B Shohet
Journal:  J Exp Med       Date:  1985-08-01       Impact factor: 14.307

View more
  36 in total

Review 1.  Accommodation in organ transplantation.

Authors:  Raymond J Lynch; Jeffrey L Platt
Journal:  Curr Opin Organ Transplant       Date:  2008-04       Impact factor: 2.640

2.  Exposure to the common food additive carrageenan leads to glucose intolerance, insulin resistance and inhibition of insulin signalling in HepG2 cells and C57BL/6J mice.

Authors:  S Bhattacharyya; I O-Sullivan; S Katyal; T Unterman; J K Tobacman
Journal:  Diabetologia       Date:  2011-10-20       Impact factor: 10.122

3.  Removal of anti-Galalpha1,3Gal xenoantibodies with an injectable polymer.

Authors:  Andreas G Katopodis; Richard G Warner; Rudolf O Duthaler; Markus B Streiff; Armin Bruelisauer; Olivier Kretz; Birgit Dorobek; Elke Persohn; Hendrik Andres; Alain Schweitzer; Gebhard Thoma; Willy Kinzy; Valerie F J Quesniaux; Emanuele Cozzi; Hugh F S Davies; Rafael Mañez; David White
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

4.  Rapid recruitment and activation of macrophages by anti-Gal/α-Gal liposome interaction accelerates wound healing.

Authors:  Kim M Wigglesworth; Waldemar J Racki; Rabinarayan Mishra; Eva Szomolanyi-Tsuda; Dale L Greiner; Uri Galili
Journal:  J Immunol       Date:  2011-02-25       Impact factor: 5.422

5.  Increased immunogenicity of human immunodeficiency virus gp120 engineered to express Galalpha1-3Galbeta1-4GlcNAc-R epitopes.

Authors:  Ussama Abdel-Motal; Shixia Wang; Shan Lu; Kim Wigglesworth; Uri Galili
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

Review 6.  Immunological challenges and therapies in xenotransplantation.

Authors:  Marta Vadori; Emanuele Cozzi
Journal:  Cold Spring Harb Perspect Med       Date:  2014-04-01       Impact factor: 6.915

7.  Carrageenan Inhibits Insulin Signaling through GRB10-mediated Decrease in Tyr(P)-IRS1 and through Inflammation-induced Increase in Ser(P)307-IRS1.

Authors:  Sumit Bhattacharyya; Leo Feferman; Joanne K Tobacman
Journal:  J Biol Chem       Date:  2015-03-17       Impact factor: 5.157

Review 8.  α-Gal Nanoparticles in Wound and Burn Healing Acceleration.

Authors:  Uri Galili
Journal:  Adv Wound Care (New Rochelle)       Date:  2017-03-01       Impact factor: 4.730

9.  Intratumoral injection of alpha-gal glycolipids induces a protective anti-tumor T cell response which overcomes Treg activity.

Authors:  Ussama M Abdel-Motal; Kim Wigglesworth; Uri Galili
Journal:  Cancer Immunol Immunother       Date:  2009-01-28       Impact factor: 6.968

10.  Carrageenan-induced innate immune response is modified by enzymes that hydrolyze distinct galactosidic bonds.

Authors:  Sumit Bhattacharyya; Haiying Liu; Zhenqing Zhang; Murielle Jam; Pradeep K Dudeja; Gurvan Michel; Robert J Linhardt; Joanne K Tobacman
Journal:  J Nutr Biochem       Date:  2009-10-28       Impact factor: 6.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.